| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 132.832 | 126.597 | 119.271 | 123.573 | 172.278 | 269.648 | 237.516 | 200.126 | 221.767 | 257.163 |
| Total Income - EUR | 135.097 | 127.891 | 119.418 | 124.610 | 172.659 | 269.784 | 244.593 | 210.296 | 225.752 | 257.183 |
| Total Expenses - EUR | 119.254 | 130.626 | 141.796 | 120.047 | 177.148 | 250.525 | 240.236 | 207.642 | 205.356 | 238.730 |
| Gross Profit/Loss - EUR | 15.843 | -2.735 | -22.378 | 4.563 | -4.488 | 19.259 | 4.358 | 2.654 | 20.396 | 18.453 |
| Net Profit/Loss - EUR | 13.166 | -2.735 | -29.042 | 3.426 | -5.895 | 16.951 | 2.446 | 593 | 18.611 | 16.106 |
| Employees | 5 | 6 | 5 | 4 | 0 | 7 | 6 | 7 | 6 | 6 |
Check the financial reports for the company - Admedica Invest Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 123.814 | 124.952 | 113.363 | 117.888 | 106.126 | 96.760 | 87.425 | 81.085 | 74.430 | 69.285 |
| Current Assets | 105.596 | 90.583 | 66.141 | 53.144 | 27.232 | 42.946 | 45.556 | 32.786 | 46.960 | 31.934 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 525 | 2.735 | 2.630 | 1.036 | 2.858 | 18.135 | 19.723 | 27.980 | 29.528 | 21.201 |
| Cash | 105.071 | 87.848 | 63.511 | 52.108 | 24.374 | 24.811 | 25.833 | 4.806 | 17.432 | 10.733 |
| Shareholders Funds | 129.461 | 125.406 | 66.805 | 69.005 | 52.901 | 68.850 | 69.769 | 837 | 19.445 | 35.443 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 99.975 | 90.760 | 80.687 | 92.465 | 81.391 | 71.237 | 63.917 | 113.412 | 102.005 | 67.139 |
| Income in Advance | 0 | 0 | 32.836 | 10.745 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Admedica Invest Srl